The PharmaTimes portfolio includes the well-respected monthly PharmaTimes Magazine; three news elert services; business forums, where thought-leaders meet to discuss the issues of the day; and a series of awards that recognise, reward and celebrate excellence.
http://www.pharmatimes.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
6.2 seconds
16x16
32x32
Europharm Management Education Limited
Kathy King
The Coach H●●●●●●●●●●●heen Lane .
Eas●●●een , London, SW14 8NA
UNITED KINGDOM
View this contact
Sarah Bullard
The Coach ●●●●●●●●●●Sheen Lane
Eas●●●een , SW14 8NA
UNITED KINGDOM
View this contact
Thus Ltd
Demon Hostmaster
Cable&Wireless Wor●●●●●●●●●●●●●●●●●●ide House Western Road
Bra●●●ell , Berkshire, RG12 1RW
UNITED KINGDOM
View this contact
BUY YOUR DOMAIN
24
YEARS
1
MONTHS
26
DAYS
TUCOWS DOMAINS INC.
WHOIS : whois.tucows.com
REFERRED : http://domainhelp.opensrs.net
PAGES IN
THIS WEBSITE
24
SSL
EXTERNAL LINKS
402
SITE IP
185.64.253.8
LOAD TIME
6.157 sec
SCORE
6.2
PharmaTimes – in-depth news, features and insights for the pharmaceutical and healthcare sectors | pharmatimes.com Reviews
https://pharmatimes.com
The PharmaTimes portfolio includes the well-respected monthly PharmaTimes Magazine; three news elert services; business forums, where thought-leaders meet to discuss the issues of the day; and a series of awards that recognise, reward and celebrate excellence.
pharmatimes.com
Novartis' Afinitor extends progression-free survival in NET - PharmaTimes
http://www.pharmatimes.com/Article/15-05-21/Novartis_Afinitor_extends_progression-free_survival_in_NET.aspx
How does it work. How do I enter. How do I enter. How do I enter. Novartis' Afinitor extends progression-free survival in NET. Novartis says late-stage clinical data show that its cancer drug Afinitor extended progression-free survival in patients with advanced nonfunctional neuroendocrine tumours (NET) of gastrointestinal or lung origin. There are limited treatment options for patients suffering from GI or lung NET, an unmet need Novartis is hoping to address through expanding the scope of Afinitor.
Novartis COPD therapies hit Phase III targets - PharmaTimes
http://www.pharmatimes.com/Article/15-05-21/Novartis_COPD_therapies_hit_Phase_III_targets.aspx
How does it work. How do I enter. How do I enter. How do I enter. Novartis COPD therapies hit Phase III targets. A first look at data from pivotal Phase III trials assessing Novartis’ chronic obstructive pulmonary disorder medicines QVA149 and NVA237 show improvements across lung function and quality of life measures. Novartis is hoping that its medicines will help address the urgent need for new COPD treatments in the US, given that many of the 27 million patients with the condition remain symptomatic d...
FDA OK for Teva's acute asthma inhaler - PharmaTimes
http://www.pharmatimes.com/Article/15-04-01/FDA_OK_for_Teva_s_acute_asthma_inhaler.aspx
How does it work. How do I enter. How do I enter. How do I enter. FDA OK for Teva's acute asthma inhaler. US regulators have issued a green light for Teva’s ProAir RespiClick (albuterol sulfate inhalation powder), the first breath-actuated dry-powder inhaler cleared for acute asthma symptoms. Approval was based on data from eight clinical trials showing that ProAir RespiClick was safe and effective, with a side-effects profile consistent with that seen in earlier albuterol inhalers. This field is required.
NICE under fire over guidance for MS drugs Fampyra, Sativex - PharmaTimes
http://www.pharmatimes.com/Article/14-06-10/NICE_under_fire_over_guidance_for_MS_drugs_Fampyra_Sativex.aspx
How does it work. How do I enter. How do I enter. How do I enter. NICE under fire over guidance for MS drugs Fampyra, Sativex. Multiple sclerosis specialists have urged the UK cost watchdog not to block two potentially life-changing drugs that alleviate the symptoms of the disease. In a letter to the. In a statement sent to. He added that a detailed analysis of the evidence of costs and benefits of Fampyra and Sativex led us to conclude that neither should be recommended by NICE as they do not currently ...
Horizon and its 'patients in a test-tube' to float - PharmaTimes
http://www.pharmatimes.com/Article/14-02-27/Horizon_and_its_patients_in_a_test-tube_to_float.aspx
How does it work. How do I enter. How do I enter. How do I enter. Horizon and its 'patients in a test-tube' to float. The UK biotech sector has been boosted by news that Horizon Discovery plans to raise 25 million by listing on the London Stock Exchange's Alternative Investment Market. This approach of helping to identify the right drugs for the right patients has attracted a number of partners and Horizon has a number of big pharma deals in place, with the likes of Novartis, Bayer, Boehringer Ingelheim ...
TOTAL PAGES IN THIS WEBSITE
24
Probert Consulting Index
http://www.probertconsulting.co.uk/index.html
Probert Consulting Ltd Index. Specialists in Pharmaceutical Marketing. Not everything that can be counted counts and not everything that counts can be counted". Working together to maximise your sales potential. With over 15 years of pharmaceutical experience that covers the whole product life cycle, from development, registration, launch and patent expiry, Probert Consulting offers dedicated and tailored resource as and when your team needs it. Key Opinion Leader Development.
Partners & Associates - CSL
http://www.csl-uk.com/partners
Business intelligence and data management solutions. Partners & Associates. CSL are proud to work in partnership and be associated with a number of companies including:-. Provides HTML5-based app development tools and services for building universal apps that run on any device. Visit the Sencha website. Microsoft is a world leader in computer and software technology. Visit the Microsoft website. PharmaTimes Magazine was launched in 1988 and was the first independent monthly for the pharmaceutical, biotec...
Flu Crazy: February 2013
http://flucrazy.blogspot.com/2013_02_01_archive.html
Flu Crazy the science, politics, and news of influenza. Friday, February 8, 2013. Flu cases drop again. 2,362 Lab Confirmed cases. Flu cases, as reported to the CDC have dropped again to 2,362 laboratory confirmed cases (FluView: http:/ gis.cdc.gov/grasp/fluview/fluportaldashboard.html. This marks 5 consecutive weeks that lab-confirmed cases have dropped. But, since CDC keeps revising numbers for previous weeks, this is hard to pin down. We are still waiting for major media outlets to pick up this story.
Flu Crazy: March 2012
http://flucrazy.blogspot.com/2012_03_01_archive.html
Flu Crazy the science, politics, and news of influenza. Tuesday, March 20, 2012. Flu Crazy 200 - The Largest Pharmaceutical Companies in the world, by size. Flu Crazy 200 - The Largest Pharmaceutical Companies in the world, by size. Merck & Co.,. Alexion Pharmaceuticals, Inc. Valeant Pharmaceuticals International,. Cardinal Health, Inc. Eisai Co.,Ltd. Regeneron Pharmaceuticals, Inc. Watson Pharmaceuticals, Inc. Kangmei Pharmaceutical Co.,. IDEXX Laboratories, Inc. Hisamitsu Pharmaceutical Co.,. We recogn...
Flu Crazy: November 2013
http://flucrazy.blogspot.com/2013_11_01_archive.html
Flu Crazy the science, politics, and news of influenza. Tuesday, November 12, 2013. CDC admits flu shot link to febrile seizures. The CDC now admits that there is a verifiable link between the flu shot and seizures in children ("febrile seizures"). In a conversation with medical web site WebMD, Frank DeStefano, confirms the link when children get the flu shot with other vaccines (specifically the pneumococcal PCV13 vaccine). Links to this post. Subscribe to: Posts (Atom). Subscribe To Flu Crazy. CDC DEAT...
Useful Links | BiKiE
http://www.bikie.org/useful-links
Bio Korea in Europe. Mission & Activities. Resources for BiKiE Members. Conferences & Meetings. Research Funding & Grants. News & announcements. Questions & Answers. Korea and Global Partners in Pharma, Biotech, and Life Sciences. Korea bio-pharma network – 바이오 제약 산업 종사자 모임. Europe, Canada, Israel ERA-NET Neuron. International stem cell forum. Pharm Tech: http:/ www.pharmtech.com/. Pharma Times: http:/ www.pharmatimes.com/. BBC Health News: http:/ www.bbc.co.uk/news/health. Eucomed: http:/ www.eucome...
Akshaya Labs - Global Pharma & Health Care Sourcing Partner
http://www.akshayalabs.in/index.php
Content on this page requires a newer version of Adobe Flash Player. Raquo; Express Pharma Online. Raquo; Pharma Times. Raquo; Indian Journal of Pharma Science. Raquo; Med India. Raquo; Pharma Focus Asia. Raquo; Pharma Magazine. Raquo; Pharma Buzz. Raquo; Indian Pharmaceutical Association. Raquo; Dapoxetine HCl. Raquo; EMU OIL. Raquo; Ethyl Maltol. Raquo; (R)-Methyl 3-Hydroxybutanoate. Raquo; Coenzyme Q10. Raquo; Ethyl Vanillin. Akshaya Laboratories Pvt Ltd.,. 104,Balaji Hills Apts, I Bhagya Nagar colony,.
PharmaTimes | PharmaTimes Clinical Researcher of the Year - The Americas | Key Dates
http://www.usclinicalresearcher.com/keydates.aspx
Why should I enter? How does it work? The competition outside the Americas. Competition launches for 2016. Stage 2 Clinical Challenges are available. Please note: Although the multiple choice questionnaire is available from October 23 up until the closing date of January 29 2016, contestants are advised to complete Stage 1 at their earliest convenience in order to give themselves time to complete Stage 2. The pass mark for Stage 1 is 70%. Competition closes. No entries can be submitted after this date.
TOTAL LINKS TO THIS WEBSITE
402
Willkommen bei pharmatime, Österreichs unabhängigem Apothekermagazin
Ouml;sterreichs Apothekermagazin unabhängig • meinungsbildend • kritisch. 2018 Pharma-Time Verlags GmbH Mediadaten 2018.
PharmaTime - Software for the financial management of clinical trials
Manage your clinical trial resources, projects, expenses and finances in one application. Technology for your business. PharmaTime is a flexible software platform which can be customised for your needs. On all your clinical trial activities. Keep track of your progress through our standard suite of reports clinical trial dashboards and KPIs. Track every aspect of your clinical trials such as staff hours, business expenses and project financials. SOPs Compliance for Clinical Trials. 61 3 9642 2082.
Pharmatime - Prenotazione Agenda Farmacia
Vuoi richiedere un preventivo? I servizi della Farmacia. A portata di click. Qualità, servizi, offerte, appuntamenti tutto a portata di click. 2015 la svolta irreversibile nel modo di navigare. Sciegliere quando vuoi, il servizio che fa per te e prenotarlo subito. Sui servizi della tua Farmacia. Backoffice semplice ed intuitivo per gestire dagli eventi ai trattamenti in cabina. Via Pisa 250 - Sesto San Giovanni - MI. Telefono: 02.87.38.64.70. Piva 11962560154 - Privacy Policy.
Pharmatime - HOME
Pharma Time will explore directly the components that impact pharmacists and their businesses in a fresh, incisive and personal way and we will assist candidates to find the right job and clients to fulfill their staffing requirements. Issue 13 - 2015. Tel and Fax: 002-02-24156862 Mobile: 002-011-9724708 Email: This email address is being protected from spambots. You need JavaScript enabled to view it. Post Office: 11371 - BOX 8203.
Welcome To PharmaTimes
RNI NO. DELBIL/2008/23916. Transparency provisions intact as political agreement reached on CT regulation. Committee of Permanent Representatives adopts overhaul of clinical-trials Directive. How will value based assesment affect you? View Latest Issue of Pharmatimes Magazine. Parliament will debate on Pharma Policy. RANBAXY RECEIVES FINAL APPROVAL FROM U.S. FDA TO MANUFACTURE AND MARKET. NIH study shows enzyme that produces melatonin originated 500 million years ago. Lupin launches HIV drug in US.
PharmaTimes – in-depth news, features and insights for the pharmaceutical and healthcare sectors
Marketer of the year. How the Competition Works. How the Competition Works. How do I enter. How do I enter. Clinical Researcher - The Americas. How does it work. April issue out now! Feat: The future of digital in pharma; Drugs that track adherence; New medical device regulations; 2018's most important IP cases. What's next for digital in pharma? Digital sensor medicines: the holy grail in adherence? Will drugs that track adherence when ingested be a tough pill for patients to swallow? The Pharma Fast 50.
Index of /
Apache/2.2.27 (Unix) mod ssl/2.2.27 OpenSSL/0.9.8e-fips-rhel5 mod bwlimited/1.4 mod fcgid/2.3.9 Resin/3.1.10 Sun-ONE-ASP/4.0.3 Server at www.pharmatimes.com.ng Port 80.
PharmaTimes
Get news headlines by email. Get jobs by email. Website and Archive search. Subscribe to the archive. Lilly hit by spectacular failure of Phase III Alzheimer’s candidate. There was more bad news for Eli Lilly following the spectacular failure of its late-stage Alzheimer’s disease candidate, and a new question mark over the future of Cymbalta in chronic pain. BioMarin snaps up ZyStor and new Pompe candidate for $115m. More World News articles. Shire pulls ProAmatine from the market. NHS told to plan for n...
Pharmatimes.net
The domain pharmatimes.net has expired. If you registered this domain name as a direct customer of Melbourne IT, please click here. To renew your domain name. If you registered this domain name via a reseller of Melbourne IT, please contact the reseller to renew this domain.
pharmatimesclinical.com
Domain pending ICANN verification.
This domain name is pending ICANN verification. Welcome to pharmatimescompetitions.com Domain name registered by 123Reg/Webfusion. Please be advised that as of the 1st January 2014 it has now become a mandatory requirement from the Internet Corporation for Assigned Name and Numbers (ICANN) that all ICANN accredited registrars verify the WHOIS contact information for all new domain registrations, domain transfers and registrant contact modifications. Why has this domain been suspended? If you have not rec...
SOCIAL ENGAGEMENT